Natco Pharma Limited has informed the Exchange regarding Notice of 42nd Annual General Meeting to be held on September 25, 2025 at 11:00 AM through Video Conference /Other Audio Visual Means
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has notified the exchanges about its 42nd AGM scheduled for Thursday, September 25, 2025 at 11:00 AM, to be held via video conferencing. Shareholders will vote on adopting FY25 audited financial statements and confirming three interim dividends totaling ₹6.00 per share as the FY25 dividend. Key special business items include seeking approval to raise the company's borrowing limit to ₹1,000 crores, allowing creation of charges on company assets as security, and increasing authorised share capital from ₹40 crore to ₹45 crore (divided into 22.5 crore equity shares of ₹2 each). Vice Chairman & CEO Rajeev Nannapaneni is also up for re-appointment as a director liable to retire by rotation. E-voting will be open from September 22 (9:00 AM) to September 24 (5:00 PM), with cut-off date of September 19, 2025.
The proposed increase in authorised share capital and borrowing limit to ₹1,000 crores signals potential expansion plans or capital needs ahead, which shareholders should evaluate. Confirmation of ₹6.00 per share total dividend provides clarity on FY25 returns, while the e-voting window allows retail shareholders to participate remotely in these governance decisions.